Shots:Thierry spoke about the IND clearance of its lead candidate in hypoparathyroidism and the company’s clinical trial plans for rare endocrine and related diseasesThierry also communicated about the closing of funding Series B equity financing roundThe interview gives a deeper understanding of Hypoparathyroidism and its treatment optionsSmriti: What did this Investigational…
